Chesapeake Ghost Tours Offers 70 Haunted Experiences Across Maryland's Eastern Shore This October

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in...

Tampa Bay Homeowners Urged to Book EV Charger Installs Before the Holidays

New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives...

INVESTOR ALERT: Webull Corporation Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 7, 2026 Deadline,...

Dietz Electric Releases Updated Guide to the Types of Electric Motors

Bronstein, Gewirtz & Grossman LLC Urges Netcapital Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Readout - Prime Minister Carney speaks with President of the United States Donald J. Trump

Purina and Mariska Hargitay Bring the Purple Leash Project to U.S. Soccer, Launch Limited-Edition Scarves Supporting Abuse Survivors and...

Glen Pankhurst Shares Personal Exchange With Abraham-Hicks

First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on...

Edison Contractor Offers 28 Years of Home Addition Services

Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S....

86-Year Danville Dealer Expands New and Used Inventory

Prime Minister Carney speaks with President of Ukraine Volodymyr Zelenskyy

Bronstein, Gewirtz & Grossman LLC Urges Coastal Financial Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show

Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of...

Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel...